Censorship in cancer research and information can occur for several reasons. Some common motives include protecting proprietary information, preventing public panic, and avoiding the dissemination of unverified or potentially harmful data. Additionally, financial interests can play a role, as pharmaceutical companies and other stakeholders may seek to control information to protect their investments.
